Skip to main content
. 2024 Nov;18(3):7–15. doi: 10.5704/MOJ.2411.002

Table I.

Baseline demographic and clinical data of patients in Group A (Corrected after surgery), Group B (Corrected before surgery) and Group C (No Vitamin D deficiency).

Variables Group A Group B Group C Overall
Number of patients (n) 80 80 80 240
Mean Age (years) 64.34 ± 8.54 65.46 ± 8.20 64.62 ± 8.20 64.8 ± 8.29
Gender        
 Males 29 (36.3%) 28 (35%) 29 (36.3%) 86 (35.83%)
 Females 51 (63.7%) 52 (65%) 51 (63.7%) 154 (64.17%)
Side affected        
 Dominant 41 (51.25%) 40 (50%) 42 (52.5%) 123 (51.25%)
 Non-dominant 39 (48.75%) 40 (50%) 38 (47.5%) 117 (48.75%)
Mean Body Mass Index (kg/m2) 27.24±2.38 26.8±2.97 27.15±2.04 27.06±2.48
Pre-operative Vitamin D (ng/ml) 16.8±6.08 51.02±6.45 48.6±7.32 38.81±6.62
12 weeks follow-up Vitamin D (ng/ml) 52.37±6.74 50.48±6 47.95±7.18 50.26±19.92
Comorbidities (on medication)        
 Hypertension 24 (30%) 22 (27.5%) 22 (27.5%) 68 (28.33%)
 Diabetes Melltitus (HBA1c<8%) 4 (5%) 6 (7.5%) 3 (3.75%) 13 (5.42%)
 Hypothyroidism 2 (2.5%) 1 (1.25%) 2 (2.5%) 5 (2.08%)
 Ischemic Heart disease 2 (2.5%) 3 (3.75%) 3 (3.75%) 8 (3.33%)
 Anxiety/ Depression 1 (1.25%) 1 (1.25%) 1 (1.25%) 3 (1.25%)
Socioeconomic status (Modified Kuppuswamy scale)        
 Upper 17 (21.25%) 15 (18.75%) 16 (20%) 58 (24.17%)
 Upper middle 16 (20%) 16 (20%) 18 (22.5%) 50 (20.83%)
 Lower middle 24 (30%) 27 (33.75%) 26 (32.5%) 67 (27.92%)
 Upper Lower 23 (28.75%) 22 (27.5%) 20 (25%) 65 (27.08%)
 Lower 0 (0%) 0 (0%) 0 (0%) 0

Notes: All values presented as mean ± standard deviation (95% confidence interval) or number (percentage)